Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001085829 | SCV000283127 | benign | Bloom syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000271833 | SCV000339649 | uncertain significance | not provided | 2016-02-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000572201 | SCV000672928 | likely benign | Hereditary cancer-predisposing syndrome | 2016-11-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000572201 | SCV002531772 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-21 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000271833 | SCV004222464 | likely benign | not provided | 2023-01-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003897510 | SCV004717797 | likely benign | BLM-related condition | 2021-09-14 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001085829 | SCV002088125 | benign | Bloom syndrome | 2019-06-24 | no assertion criteria provided | clinical testing |